KRYS — Krystal Biotech Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Krystal Biotech Inc (KRYS), worth $28.54M combined. Over the quarter 3 opened or added, 2 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $22.18M | 0.03% | +521.7% |
| VanEck | $6.34M | 0.00% | NEW |
| Persistent | $18.21K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.